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Efficiency of lymphoma induction by herpesvirus saimiri (HVS) isolates correlates with the genetically defined viral
subgroups A, B, and C. To compare subgroup-specific effects, highly susceptible tamarins were infected with HVS strain A-11,
B-SMHI, or C-488. All animals developed T-cell lymphomas indistinguishable with respect to clinical, pathological, and
virological parameters. Ex vivo T-cell lines were established readily from the HVS C-488 animal, less efficiently in the
presence of HVS A-11, and from only a single HVS B-SMHI sample. These cultivated cells revealed strain-specific
biochemical characteristics. HVS A-11 strongly induced the expression of tyrosine kinase Lyn. HVS C-488 led to the
activation of STAT3, which is most likely linked to the association of virus-encoded Tip with tyrosine kinase Lck. The lack of
these activities in HVS B-SMHI-transformed cells may correlate with the reduced oncogenic phenotype of this virus inINTRODUCTION
Saimiriine herpesvirus 2, or herpesvirus saimiri (HVS)
(Albrecht et al., 1992; Melendez et al., 1968), is the pro-
totype member of the 2 or rhadinovirus subfamily of
herpesviruses, which also comprises the closely related
herpesvirus ateles (Albrecht, 2000; Melendez et al.,
1972b), Kaposi’s sarcoma-associated herpesvirus or hu-
man herpesvirus 8 (Chang et al., 1994; Russo et al., 1996),
and a growing number of Old World primate rhadinovi-
ruses (Greensill and Schulz, 2000). The linear DNA ge-
nomes of rhadinoviruses consist of a central coding
region flanked by noncoding repetitive elements. Within
the subfamily, viral genes show a colinear organization
which is disrupted by clusters of specific genes. The
latter are frequently homologous to cellular cDNAs and
are considered to be involved in pathogenesis by the
individual virus species. Among HVS isolates, a specific
region at the left terminus of the coding sequences is
highly variable, leading to the definition of viral sub-
groups A, B, and C (Biesinger et al., 1990; Desrosiers and
Falk, 1982; Geck et al., 1990; Ho¨r et al., 2001; Medveczky
et al., 1984; Murthy et al., 1989). The genetic subgroup
assignment correlates with the divergent pathogenic
properties of individual HVS strains.
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dressed at the Abteilung Molekularbiologie, Max-Planck-Institut fu¨rNo apparent disease is associated with HVS infection of
the natural host, the squirrel monkey (Saimiri sciureus) (Falk
et al., 1973b), in which it persists in and is readily recovered
from peripheral blood cells (Desrosiers and Falk, 1982; Falk
et al., 1972, 1973a; Wright et al., 1976). In contrast, inocula-
tion of other New World primates and of some distinct
rabbit strains results in fatal T-cell lymphoma and leukemia
with varying efficiency depending on the animal species
and on the viral subgroup used for experimental infection.
The original HVS isolate S295C/SMKI 83 (Melendez et al.,
1968), a member of HVS subgroup B (Medveczky et al.,
1984), was found to be pathogenic in cottontop tamarins
(Saguinus oedipus) (Hunt et al., 1970; Laufs and Flecken-
stein, 1973; Wolfe et al., 1971), whitelip tamarins (Sag. fus-
cicollis/nigricollis) (Wolfe et al., 1971), owl monkeys (Aotus
trivirgatus) (Ablashi et al., 1971; Hunt et al., 1970; Melendez
et al., 1970a, 1971), spider monkeys (Ateles geoffroyi) (Hunt
et al., 1972), and howler monkeys (Alouatta caraya) (Rangan
et al., 1977). Contradictory results are published as to dis-
ease development in response to subgroup B infection of
capuchin monkeys (Cebus albifrons) (Melendez et al.,
1970b; Rabin et al., 1975), common marmosets (Callithrix
jacchus) (Laufs and Fleckenstein, 1973; Laufs et al., 1974;
Wright et al., 1977), New Zealand White rabbits (Daniel et
al., 1974; Medveczky et al., 1989; Rangan et al., 1976), and
the Old World primate species, African green monkeys
(Cercopithecus aethiops) (Laufs and Fleckenstein, 1973;
Melendez et al., 1972a).
HVS subgroup A strain 11 (HVS A-11) induces lympho-species other than tamarins. © 2002 Elsevier Science (USA)
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lip tamarins (Falk et al., 1972), owl monkeys (Desrosiers
et al., 1985), and common marmosets (Wright et al., 1977).
This virus isolate tested nononcogenic in rabbits (Med-
veczky et al., 1989). In contrast, HVS strains of subgroup
C induced lymphoproliferative disorders not only in cot-
tontop (Knappe et al., 1998b) and common marmosets
(Duboise et al., 1998a), but also in rabbits (Medveczky et
al., 1989), rhesus macaques (Alexander et al., 1997), and
cynomolgus monkeys (Knappe et al., 2000).
Continuously proliferating T-cell lines may be obtained
either by cultivation of blood or tumor samples of in-
fected animals (Fleckenstein and Desrosiers, 1982) or by
infection of isolated lymphocytes. In vitro transformation
by HVS is again restricted by the virus subgroup and by
the species of the recipient. HVS subgroup A strains
were used to infect peripheral blood lymphocytes from
cottontop, owl, spider, and capuchin monkeys but re-
sulted in only a single cottontop lymphocyte line (Schirm
et al., 1984). In contrast, they efficiently immortalize com-
mon marmoset T-cells (Desrosiers et al., 1986; Szomola-
nyi et al., 1987). HVS subgroup B strains inefficiently
transform interleukin-2 (IL-2) expanded lymphocytes of
owl monkeys and common marmosets (Rabin et al.,
1984; Szomolanyi et al., 1987). As in the in vivo experi-
ments, in vitro transformation by HVS subgroup C strains
shows an extended host range. They efficiently immor-
talize lymphocytes from common marmosets (Desrosiers
et al., 1986; Szomolanyi et al., 1987) and whitelip (Knappe
et al., 1997) and cottontop tamarins (Glykofrydes et al.,
2000). In addition, they transform human (Biesinger et al.,
1992) and rhesus monkey (Akari et al., 1996) T-lympho-
cytes to permanent growth in culture.
As shown for HVS subgroups A and C, oncogenesis
and in vitro transformation depend on the subgroup-
determining region of the viral genome which is not
required for replication (Desrosiers et al., 1984, 1985,
1986; Duboise et al., 1998a; Knappe et al., 1997; Koomey
et al., 1984; Medveczky et al., 1989). The stp genes
identified in this region (Biesinger et al., 1990; Choi et al.,
2000; Geck et al., 1990; Ho¨r et al., 2001; Lee et al., 1997;
Murthy et al., 1989) code for subgroup-specific proteins
designated StpA, StpB, StpC, and Tip. Stable expression
of StpA and StpC induces morphological transformation
of rodent fibroblasts, whereas StpB and Tip tested neg-
ative in this system (Choi et al., 2000; Jung et al., 1991). In
transgenic mice, expression of StpA and Tip results in
lymphoma (Kretschmer et al., 1996; Wehner et al., 2001)
while StpC induces epithelial tumors (Murphy et al.,
1994). In HVS-transformed human lymphocytes, Tip and
StpC are expressed from a bicistronic mRNA (Ficken-
scher et al., 1996) and both reading frames are required
for the oncogenic phenotype of the parental virus strain
(Duboise et al., 1998a). Although expression of StpA or
StpB in immortalized monkey T-lymphocytes has not
been demonstrated so far, they are assumed to influence
the proliferation of these cells.
The biological functions of the transformation-associ-
ated HVS proteins are considered to be mediated by
their cellular binding partners. All Stp proteins interact
with TNF receptor-associated factors (TRAFs), but only
StpC activates their downstream effector, NFB (Choi et
al., 2000; Lee et al., 1999). In addition, StpC associates
with cellular Ras and leads to its activation in stably
transfected fibroblasts (Jung and Desrosiers, 1995a).
StpA as well as StpB binds to the SH2 domain of tyrosine
kinase c-Src after overexpression, but activation of the
enzyme has not been observed (Choi et al., 2000; Ho¨r et
al., 2001; Lee et al., 1997). Tip was identified as an
interaction partner of the tyrosine kinase Lck in HVS
C-488-transformed T-lymphocytes (Biesinger et al., 1995)
and has been described as an activator (Hartley et al.,
1999; Lund et al., 1997a; Wiese et al., 1996) as well as an
inhibitor (Guo et al., 1997; Jung et al., 1995c) of this
tyrosine kinase. Tip also associates with and activates
signal transducers and activators of transcription (STAT)
in overexpression systems (Hartley and Cooper, 2000;
Lund et al., 1997b). Consequently, all stp gene products
may alter cellular functions in order to allow viral persis-
tence and proliferation of infected cells.
To define differences in disease development and to
analyze cellular functions altered by the viral transforma-
tion-associated proteins, we here compared tissue sam-
ples and cell lines derived from Sag. oedipus infected
with HVS from the three subgroups. While all virus
strains used were pathogenic in this highly susceptible
host, differences in the outgrowth of tumor cells and in
cellular protein expression and activation may correlate
with the reduced transformation capacity of HVS sub-
group B isolates in other biological systems.
RESULTS
Three adult monkeys of the species Sag. oedipus were
infected with HVS A-11, B-SMHI, or C-488, respectively.
Within 26 days, all three animals developed typical symp-
toms. A complete necropsy was performed on each animal
and revealed low- to high-grade hyperplasia of lymph
nodes, tonsils, spleen, and kidneys as well as discolored
foci in liver and renal cortex indicative of malignant lym-
phoma. Representative samples of all major organs and
tissues were collected for further analyses (Table 1).
Histopathology
Histological examination of paraffin-embedded tissue
samples revealed extensive and diffuse infiltration of
most tissues by medium-sized to large pleomorphic lym-
phoid cells. Mitotic figures and apoptotic bodies were
frequent and there were foci of necrosis (Table 1 and Fig.
1). In the lungs, infiltration was mainly peribronchial (data
not shown) and in the liver it was centered on portal
tracts with a minor sinusoidal component (Fig. 1, HVS
C-488). The only organ lacking lymphoma infiltration in
all animals was the pancreas. In addition, gastric mu-
cosa was negative in the HVS A-11-infected tamarin.
32 REISS ET AL.
Myocardium, adrenal, duodenum, and gastric mucosa
were not available for histopathological examination of
the HVS C-488-infected animal (Table 1). The central
nervous system was not examined in any of the animals.
Immunohistochemical staining of lymphoma samples
from all tamarins revealed expression of CD3 (Fig. 1,
right) and absence of CD20 (data not shown) expression.
Thus, these findings conformed to a diagnosis of periph-
eral medium-sized to large cell T-cell non-Hodgkin lym-
phoma (Harris et al., 1994). There were no differences
between the animals with regard to morphology and
extent of the lymphoma infiltrates.
Virus reisolation from tissue samples
Supernatants from transportation and from the first
incubation period of the fresh tissue samples were used
for the infection of permissive owl monkey kidney (OMK)
cells. The results of three independent assays are sum-
marized in Table 1. Infectious virus was detectable in
most of the tissues from the HVS A-11- and B-SMHI-
infected animals. Duodenum samples of both tamarins
as well as liver, lung, and salivary gland from HVS A-11
infection tested negative. Only a limited number of HVS
C-488-infected tissues were available. They showed a
lower efficiency of virus reisolation, which may be due to
transport conditions (see Material and Methods). Thus,
viral spread in vivo was similar for HVS A-11 and B-SMHI
while evaluation of HVS C-488 was restricted. Finally,
there was no correlation between virus reisolation and
lymphocytic tissue infiltration of the individual organs.
Generation and characterization of ex vivo cell lines
Fresh tissue samples from all animals (see Table 1,
virus columns) as well as blood samples from the HVS
B-SMHI- and C-488-infected monkeys were cultivated in
complete RPMI medium. Within 40 days under these
conditions, proliferating lymphocyte cultures evolved
from all HVS C-488 samples and from spleen and lymph
nodes of the HVS A-11-infected tamarin. Initial signs of
proliferation had also been observed after 15 days in the
HVS B-SMHI blood sample. This culture as well as HVS
A-11 spleen and C-488 lymph node was split and ali-
quots were cultivated in IL-2 supplemented medium,
resulting in proliferation of all three samples. Thus, while
the generation of ex vivo cultures was very efficient for
HVS C-488 and modest for HVS A-11, the establishment
of a lymphocyte line from the HVS B-SMHI-infected Sag.
oedipus was successful only with an enriched medium
containing exogenous IL-2 (Table 2).
Both HVS A-11 lines (A17 and A37), the single HVS
TABLE 1
Analysis of Tissue Samples from HVS-Infected Sag. oedipus
Virus strain
HVS A-11 HVS B-SMHI HVS C-488
Animal 226, female 5300, male 5697, male
Time course Died 26 days p.i. Sacrificed 26 days p.i. Sacrificed 21 days p.i.
Weight
Before 620 g 700 g 640 g
After 573 g 669 g 526 g
Lymphomaa Virusb Lymphoma Virus Lymphoma Virus
Lymph nodes      
Thymus      ()
Spleen      ()
Bone marrow  n.a.c  n.a.  n.a.
Liver    ()  n.a.
Lung      n.a.
Myocardium     n.a. n.a.
Kidney      
Adrenal    () n.a. n.a.
Duodenum     n.a. n.a.
Intestines      n.a.
Ovary/testis      n.a.
Gastric mucosa  ()  () n.a. n.a.
Pancreas  ()    n.a.
Salivary gland     n.a. 
a Histological evaluation: , peripheral T cell lymphoma; , no lymphocytic infiltration.
b OMK cells treated with tissue supernatant: , CPE; (), CPE less frequent; , no CPE.
c n.a., sample not available.
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B-SMHI line (B1), and the matching HVS C-488 lines (C1,
C17, C37) were selected for further analyses. They all
were maintained in IL-2-supplemented medium for com-
parability. Their supernatants produced cytopathic ef-
fects on permissive OMK cultures while HVS C-488-
transformed human control lines, CB15 and 3C, tested
negative as expected (Table 2). Replication rates of the
tamarin lymphocytes were comparable for all samples
(Table 2). Slightly increased doubling times were ob-
served for both HVS A-11 lines, correlating with an en-
hanced adherence to the surface of tissue culture flasks.
Adhesion was also detected for cell lines C17 and C37,
but was absent in the blood-derived cultures, B1 and C1.
As the HVS B-SMHI line B1 initially depended on exog-
enous IL-2, we analyzed the survival of the tamarin cells
after IL-2 withdrawal from the culture medium (Table 2).
Lines A37 and B1 survived but replication was observed
in only one of three independent assays. Proliferation of
lines A17, C1, C17, and C37 was not reduced by this
treatment. HVS C-488-transformed control cells behaved
as expected; the rhesus line SL11 was IL-2 independent,
the human line 3C died in the absence of exogenous
IL-2, and the human line CB15, established in IL-2-free
medium but expanded in supplemented medium, did not
survive when IL-2 was abruptly removed (Table 2, col-
umn 3). Taken together, all ex vivo cell lines produced
infectious virus particles, and variation in proliferation
and IL-2 dependence was not linked to the virus strain.
The phenotype of the Sag. oedipus cells was deter-
mined by FACS analysis using cross-reactive anti-human
antibodies. Surface expression of CD2 was constantly
high, CD3 staining was positive at variable levels, and
CD20 expression was not detectable (data not shown).
Thus, in accordance with the immunohistochemical anal-
ysis of the tumor cells, the ex vivo lines were identified as
T-lymphocytes. Both HVS A-11 cell lines (A17 and A37)
were positive for CD4, line C1 was double negative, and
B1, C17, and C37 expressed CD8 at low levels (Table 2).
Given the variation in CD4 and CD8 phenotypes ob-
served after in vitro transformation (Biesinger et al., 1992;
Kiyotaki et al., 1986), the limited number of cell lines
analyzed here does not allow for conclusions on strain-
specific lymphocyte subset selectivity.
Virus persistence in tumor and ex vivo cells
To test for the presence of viral genomes in the infil-
trating lymphocytes, tumor sections were hybridized in
FIG. 1. Histological and immunohistochemical analyses of paraffin-embedded tissues from HVS-infected cottontop tamarins. HE-stained sections
of lymph node from Sag. oedipus 226 (infected with HVS A-11), of kidney from Sag. oedipus 5300 (infected with HVS B-SMHI), and of liver from Sag.
oedipus 5697 (infected with HVS C-488) show a polymorphic infiltrate consisting of atypical lymphocytes with pleomorphic nuclei and prominent
nucleoli (left, HE, arrows). The infiltrating lymphocytes are shown to be T-cells by virtue of their expression of CD3 (right, red staining).
FIG. 2. Detection of viral nucleic acids by in situ hybridization. (A) DNA in situ hybridization with an 35S-labeled probe specific for repetitive viral
DNA yields weak to moderate labeling (black silver grains) of the majority of infiltrating lymphoid cells (black arrows) in tissue sections of lymph node
from the HVS A-11-infected animal and of liver from the HVS B-SMHI-infected animal. Note that isolated cells show an intense labeling probably
indicative of viral replication. Background level of grains is seen over uninfected hepatocytes (right, white arrows). (B) In situ hybridization with
35S-labeled single-stranded RNA antisense probes specific for StpA, StpB, and StpC, respectively, results in weak to moderate labeling of a small
proportion of infiltrating lymphoid cells in tissue sections (HVS A-11, lymph node; HVS B-SMHI, liver; HVS C-488, liver). Using the corresponding sense
control probes, isolated cells are labeled in the lymph node from the HVS A-11-infected animal probably indicating cross-hybridization with replicating
viral DNA (see text). Hybridization with the sense control probes reveals background distribution of grains only in the other two animals.
TABLE 2
Characterization of Established Sag. oedipus Cell Lines
Name Source Virusa Doubling timeb
Survival w/o IL-2c
Phenotyped1 2 3
A17 Spleen Pos. 5 days    CD4CD8
A37 Lymph nodes Pos. 5 days  ()  CD4CD8
B1 Blood Pos. 3–4 days    CD4CD8
C1 Blood Pos. 3–4 days    CD4CD8
C17 Spleen Pos. 3–4 days    CD4CD8
C37 Lymph nodes Pos. 3–4 days    CD4CD8
CB15 Human Neg. n.d.e    CD4CD8
3C Human Neg. n.d.    CD4CD8
SL11 Rhesus n.d. n.d. ()   n.d.
a CPE on OMK cells induced by cell culture supernatant.
b In IL-2 medium; adherent cells not quantified.
c Influence of IL-2 withdrawal on cell survival analyzed in three independent experiments:, cell death;, no proliferation;, proliferation;,
enhanced proliferation.
d Expression of surface marker analyzed by FACS.
e n.d., not done.
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situ with repetitive HVS A-11 DNA. The vast majority of
HVS A-11 and B-SMHI tumor cells showed moderate
nuclear labeling indicative of latent viral infection. The
intense signal observed in a small subset of cells most
likely reflected virus replication (Fig. 2A). Sections of the
animal infected with HVS C-488, which shares a reduced
homology with A-11 terminal repeats, could not be inter-
preted due to strong nonspecific background signals
(data not shown). The ex vivo cell lines were analyzed by
PCR on total cellular DNA (Fig. 3A). Universal HVS prim-
ers binding to ORF3 and ORF75 sequences of all virus
strains gave rise to the expected fragments in samples
derived from HVS infected Saguinus monkeys (A17, A37,
B1, C1, C17, C37, 1670, 70N2) or from in vitro transforma-
tion of human lymphocytes (CB15) but not in uninfected
Sag. oedipus (B133) or human leukemia (Jurkat) controls
(Fig. 3A, top). Specific primers binding to stp sequences
were used to identify the individual virus strains (Fig. 3A,
bottom three gels). The 491-bp fragment from the stpA
region was amplified from all HVS A-11 samples (A17,
A37, 1670, 70N2). The stpB primers produced distinct
background bands in Saguinus (B133) and human (Jur-
kat) DNA. In addition, the specific fragment of 512 bp was
detected in the HVS B-SMHI line (B1). Primers binding to
the stpC gene resulted in the expected 710-bp fragment
when DNA from HVS C-488 cells was used as template
(C1, C17, C37, CB15). These results demonstrated the
presence of viral genomes in tumor as well as ex vivo
cells and excluded cross contamination among infected
animals or cultures.
Transcription of stp genes
The transforming phenotypes of HVS A-11, C-484, and
C-488 depend on the respective stp genes, implicating
that their expression is required to induce and/or main-
tain T-lymphocyte proliferation. Transcription in tumor
cells was analyzed by in situ hybridization with antisense
probes of the reading frames for StpA, StpB, and StpC
(Fig. 2B). Positive lymphocytes were observed in all sam-
ples analyzed, but for all three virus strains they repre-
sented only a fraction of the tumor cells. Control hybrid-
izations with sense transcripts were negative in the case
of StpB and StpC. Some cells reactive with the StpA
sense probe were detected in the lymph node sections
from the HVS A-11-infected animal, most likely reflecting
hybridization of the sense probe to replicating viral DNA
as described previously for Epstein–Barr virus
(Niedobitek et al., 1991). The lack of such cells in the liver
sections hybridized with StpB or StpC probes may be
related to variation of viral replication rates in different
organs (Table 1, lymph node versus liver). To detect
transcripts in the ex vivo cell lines, RT-PCR was per-
formed using stp-specific primers (Fig. 3B). The expected
fragments were amplified from RNA of all lymphocyte
lines carrying the appropriate HVS strain (compare to
Fig. 3A). Control PCRs without reverse transcriptase
were always negative, excluding contamination of RNA
preparations with genomic DNA (Fig. 3B, bottom). Thus,
transcripts of all three stp genes were detectable in a
FIG. 3. Detection of viral nucleic acids in ex vivo cell lines. (A) PCRs
were performed to detect HVS genomes in DNA preparations from the
indicated cell lines. Two primer pairs specific for ORF3 and ORF75, gen-
erating fragments of 513 and 360 bp, respectively, were used in a single
reaction to detect genomes of any HVS strain. The presence of the
strain-specific stp genes was analyzed with primer pairs for stpA, stpB,
and stpC, resulting in specific fragments of 492, 513, and 710 bp, respec-
tively. (B) Total cellular RNA was prepared from the indicated cell lines and
reverse transcribed to cDNA. The same primer pairs as in (A) were used
to test for strain-specific stp transcription. Plasmids carrying the se-
quences to be detected (20 ng each) were included as positive controls.
To exclude DNA contamination, control reactions were performed with
RNA preparations that were not reverse transcribed (no RT). Positions of
standard DNA fragments are given in base pairs on the left.
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subset of the tumor cells and in the ex vivo lymphocyte
cultures.
Expression of selected signaling molecules
To make sure that cellular factors known to bind to
Stps or Tip are present in the transformed lymphocytes
and to test for effects of transformation on cellular pro-
tein patterns, we analyzed the expression of the interac-
tion partners and of structurally or functionally related
signaling molecules (Fig. 4). The tyrosine kinases Lck
and Src were selected for their capability of directly
associating with Tip and StpA or StpB, respectively. The
analysis was extended to other Src-family members im-
portant in hematopoietic cell signaling, Fyn, Lyn, and
Hck. We also included signaling molecules known to act
downstream of Src-kinases in lymphocytes, the tyrosine
kinases Zap70 and Syk, the adaptor proteins LAT and
SLP76, as well as the guanine nucleotide exchange
factor Vav. Ras and TRAFs 1 through 3 were chosen for
their ability to interact with one or more of the Stp
variants. Expression was analyzed in lysates of all newly
established ex vivo lines. The primary Sag. oedipus line
B133 was included to test for the nontransformed phe-
notype and to verify antibody cross-reactivity. Jurkat and
BJAB served as human T- and B-lymphocyte controls,
respectively. Except for Lyn, protein expression in the ex
vivo cultures showed no HVS subgroup-specific varia-
tion, differences were either not detectable or specific for
individual cell lines (Fig. 4). In contrast, Lyn was highly
expressed in both HVS A-11-transformed lines and the
primary Sag. oedipus cells and in the BJAB control (Fig.
4). Long exposures revealed very low levels of Lyn in the
HVS B-SMHI and C-488 lines while Jurkat remained neg-
ative (data not shown).
Cellular tyrosine phosphorylation and kinase
association of HVS proteins
Protein tyrosine phosphorylation plays a central role in
lymphocyte activation and growth control. Thus the in-
teraction of HVS proteins with tyrosine kinases suggests
that an altered phosphorylation of cellular proteins con-
tributes to viral transformation. In vivo protein tyrosine
phosphorylation in the HVS-transformed Sag. oedipus
lymphocytes and in primary and Jurkat control cells was
analyzed by immunoblots with phosphotyrosine-specific
monoclonal antibodies (Fig. 5A). The basic phosphopro-
tein pattern was similar in all Sag. oedipus cells and
differed from the human leukemia cell line Jurkat. Bands
of approximately 60 and 90 kDa were more prominent for
the lysates of the HVS C-488 cell lines, C1 and C37. Their
intensity was low in the third HVS C-488 line, C17, as well
as in the A-11 and B-SMHI lines, A17, A37, and B1,
indicating that an increased phosphorylation of these
proteins did not necessarily accompany transformation
by subgroup C strain 488.
To assess the activity of Src-family kinases identified
as targets of viral transformation, immune complex ki-
nase assays were performed and autophosphorylation
of the kinases was analyzed (Figs. 5B–5D). In addition to
the ex vivo cell lines, Jurkat or CB15 cells were used as
T-lymphocyte and BJAB as B-lymphocyte controls. Tumor
cell line 70N2 as a Sag. oedipus control substituted for
the primary cells, B133, which were not available in
amounts sufficient for immunoprecipitation.
Lck was selected for its interaction with Tip and ac-
cordingly the viral protein was detected as a substrate
associated with this tyrosine kinase in all HVS C-488
samples (Fig. 5B). The level of autophosphorylation was
comparable among all Sag. oedipus samples, but was
significantly higher in the human control, CB15, which
was transformed by HVS C-488 in vitro. An unidentified
protein migrating at approximately 85 kDa was more
strongly phosphorylated in the immune complexes from
line A17 than in all other samples (Fig. 5B).
FIG. 4. Expression of selected signaling molecules. Equal amounts
of total cellular proteins from the ex vivo and control (B133, Jurkat, and
BJAB) cells were separated on multiple parallel gels for immunoblot
analysis. Antibodies reactive with the indicated proteins were used at
dilutions of 1:1000, except for Lck (1:106), Src (1:2000), Lyn (1:2000),
Zap70 (1:5000), and Ras (1:500).
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Src had been identified as a binding partner for StpA
and StpB in overexpression and in vitro systems. We
were now able to detect traces of StpA and StpB in Src
immune complexes derived from the HVS A-11 and B-
SMHI infected cells, respectively (Fig. 5C, bottom). Three
bands of autophosphorylated kinase most likely repre-
sented migration variants of Src itself (Kaech et al., 1991),
but cross-reactivity of the Src antibody with the closely
related kinases Fyn and Yes could not be excluded.
Signal intensity within the triplets varied with the virus
strain: fast and intermediate forms were predominantly
labeled in the HVS A-11 samples, B-SMHI showed a
preference for the fast band, and major autophosphory-
lation in the C-488 immunoprecipitates was observed on
the intermediate and slow forms. Jurkat controls behaved
like the HVS C-488 samples, while the intermediate band
was predominant for BJAB. For quantitative analysis of
Src activity, 32P incorporation into all three bands was
summarized. Comparison of kinase activity from HVS
B-SMHI cells with the C-488 samples and the control
cells did not reveal significant variation. However, a mod-
est increase in Src activity was observed in the HVS A-11
cells.
The increased expression of Lyn in the HVS A-11 cells
(Fig. 4) correlated with its high enzymatic activity in vitro
(Fig. 5D). Variable levels of Lyn autophosphorylation
were also detected in immune complexes from the other
ex vivo cell lines, but the low expression levels do not
support any conclusions on the specific activity of the
kinase. Autophosphorylation was very low in the BJAB
control relative to the high expression levels observed in
the immunoblot, suggesting a negative regulatory mech-
anism in culture. Minimal Lyn activity was found in Jurkat
cells, which tested negative for expression.
Altogether, we observed no subgroup-specific differ-
ences in Lck activity, while HVS A-11 appeared to induce
an increase in autophosphorylation of Src or a closely
related kinase. High Lyn activity in the HVS A-11 cells
was most likely the consequence of an augmented ex-
pression of the kinase. Increased Lyn autophosphoryla-
tion in two HVS C-488 lines coincided with an increased
phosphorylation of two unidentified 60- and 90-kDa pro-
teins, but the relevance of this finding is unclear as the
third C-488 cell line did not show these effects.
MAPK activities do not correlate with virus strains
Members of the MAPK superfamily are downstream
effectors of various growth-regulating signals and there-
FIG. 5. Effects on tyrosine kinase signaling functions. (A) Tyrosine
phosphorylation in vivo was analyzed by immunoblot with equal
amounts of total cell lysates from the ex vivo cell lines. B133 and Jurkat
were used as species-specific and T-cell-specific controls, respec-
tively. The antibody specific for phosphorylated tyrosine residues was
applied at a concentration of 1 ng/ml. (B–D) To analyze their activation
state, individual tyrosine kinases were immunoprecipitated from the
cell lysates and subjected to in vitro protein kinase assays. (B) Lck was
precipitated from 400 g total cellular proteins with 1 l of the specific
guinea pig serum. Arrowheads indicate the positions of autophospho-
rylated Lck and of coprecipitated, in vitro phosphorylated Tip. (C) Src
was obtained from incubation of 250 g total cellular proteins with 3 l
of purified antibodies. A longer exposure of the marked area is shown
at the bottom. Arrowheads indicate the positions of autophosphory-
lated Src in all cell lines, of StpA and its modified form, StpA*, in cell
lines A17 and A37, and of StpB in cell line B1. (D) Lyn was precipitated
by 1 l of the antibodies from 250 g total cellular proteins. Due to the
weak signals, a longer exposure of the same gel is shown for the
control lanes, BJAB and Jurkat. The arrowhead indicates the position of
autophosphorylated Lyn. (B–D) Controls without specific antibodies
showed no background signals (data not shown). For quantification, the
bands of autophosphorylated kinases from one representative experi-
ment were analyzed on a phosphoimager (Bas2000TR, Fuji, Du¨ssel-
dorf). The relative kinase activities given below the blots were calcu-
lated by dividing the values from the individual cell lines by the value of
cell line B1. Molecular weight markers are given at the left in kDa.
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fore represent potential targets of viral transformation
mechanisms. The activation status of ERK1/2, p54 JNK,
and p38 in the Sag. oedipus cell lines was analyzed by
immunoblots with phosphorylation-specific antibodies
(Fig. 6A). The levels of ERK1 and ERK2 expression as
well as the relative amounts of both kinases were about
equal among the ex vivo cell lines. The control cell lines
B133, Jurkat, and BJAB predominantly expressed ERK2.
The activity of these MAPKs was high in cell lines A37,
C1, and Jurkat; intermediate in B1 and C37; low in A17,
C17, and B133; and hardly detectable in BJAB. Thus,
although significant differences in the specific activity of
ERK1/2 were observed for the different HVS-transformed
lymphocyte lines, there was no correlation with the virus
strains present in these cells (Fig. 6A, top).
The expression of the stress-activated protein kinases
p54 JNK and p38 HOG largely correlated with their acti-
vation-specific phosphorylation in all cell lines exam-
ined, except for the control line B133, which displayed a
low expression and a relatively strong phosphorylation of
both kinases (Fig. 6A, middle and bottom). However, the
use of B133 as a nontransformed primary T-cell control is
restricted by its passage history and multiple restimula-
tions.
In summary, comparison of the ex vivo cell lines did
not provide any evidence for specific HVS subgroup-
specific alterations in MAPK activity, but changes com-
mon to all virus strains cannot be excluded.
STAT3 activation by HVS C-488
Cytokine signals mediated by STATs contribute to lym-
phocyte growth activation, and Tip of HVS C-484 has
been shown to induce STAT3 activity. Therefore, the ac-
tivation status of STAT3 was examined by immunoblots
with antibodies specific for the phosphorylated protein
(Fig. 6B). Protein expression was high in all Sag. oedipus
lines and intermediate in Jurkat and BJAB. A strong ac-
tivation-specific phosphorylation of STAT3 was detected
in all HVS C-488 cell lines. The control cell line, B133,
was also positive for STAT3 phosphorylation, reflecting
cellular activation due to repetitive restimulation in the
presence of irradiated feeder cells. A weak signal was
observed in one of the two HVS A-11 lines. These data
identified STAT3 activation as an obligatory effect of HVS
C-488 in ex vivo cell lines of the species Sag. oedipus.
DISCUSSION
We infected three cottontop tamarins with different
strains of HVS, each representing one of the subgroups
A, B, and C, in order to compare virus spreading in vivo,
distribution and phenotype of tumors, outgrowth, and
characteristics of tumor cell lines. Numerous previous
reports had demonstrated a high efficiency of lymphoma
induction by individual HVS strains in this endangered
primate species. Thus, only one animal per virus strain
was used to obtain the samples required for comparative
analyses.
Virus and lymphoma in tissue samples
As expected, all HVS strains used were tumorigenic in
cottontop tamarins. Histological and immunohistochem-
ical evaluation led to the diagnosis of peripheral T-cell
lymphoma in all organs analyzed except pancreas (Figs.
1 and 2, Table 1). This tumor phenotype had also been
found in StpA transgenic mice (Kretschmer et al., 1996)
and in paraffin sections derived from Sag. oedipus in-
fected with an unknown HVS strain in one of the initial
studies more than 30 years ago (Th. Kirchner and B.
Biesinger, unpublished; material kindly provided by M. D.
Daniel, NERPRC, Southborough, MA). The systemic dis-
semination of tumor cells within less than a month ar-
gues for a polyclonal event in response to HVS infection.
The detection of viral genomes in the majority of infiltrat-
ing lymphoma cells in tissue sections from HVS A-11-
and B-SMHI-infected tamarins indicates virus persis-
tence in the lymphoma cells. Tissue distribution of infec-
FIG. 6. Analysis of protein activities by phosphorylation-specific
antibodies. Equal amounts of the same lysates from ex vivo and control
cells were separated in parallel and analyzed by immunoblot. (A)
Expression of MAP kinases was detected with antibodies specific for
ERK1 and ERK2 (p44 and p42), JNK (p54), and HOG (p38). Phosphory-
lation-specific antibodies interacting with only the activated forms of
these proteins (pp44, pp42, pp54, and pp38) were used to analyze the
activation state of the MAP kinases. (B) Expression of STAT3 (p92) was
monitored by a specific antibody (top); the activated protein, phosphor-
ylated on tyrosine residue 705 (pp92), was detected by the phospho-
STAT3-specific antibody (bottom). Antibodies reactive with the indi-
cated proteins were used at dilutions of 1:1000, except for p44 ERK1/
p42 ERK2 (1:5000) and p54 JNK (1:500). The data shown are
representative of at least three independent experiments.
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tious virus particles was broad but not completely iden-
tical with lymphoma involvement (Table 1). This may be
due to the variable sensitivities of the detection methods,
to contamination of tissue samples from specific organs
with adjacent tumor-infiltrated lymph node tissue, or to a
lack of productive virus replication in tumor cells of
certain tissues. Irrespective of the virus strain, transcrip-
tion of the stp genes was detectable in a limited number
of infiltrating lymphocytes (Fig. 2B). Thus, HVS isolates of
the three subgroups were indistinguishable with respect
to in vivo effects in Sag. oedipus monkeys.
Ex vivo cell lines
The efficiency in establishing tumor cell lines from the
infected cottontop tamarins correlated with previous re-
ports on lymphoma development in other animal species
and on in vitro transformation by members of the HVS
subgroups (see the Introduction). However, once estab-
lished, no significant subgroup-specific differences were
detected among the cell lines with respect to growth
properties, cellular phenotype, presence of the expected
viral genomes, expression of the stp genes, or virus
production (Table 2). These novel cell lines, generated
under defined conditions and propagated in parallel,
were now used to compare HVS subgroup-specific ef-
fects on the expression and function of potential cellular
targets of viral transformation.
Biochemical characteristics of HVS C-488
lymphocytes
Due to their ability to transform human T-lymphocytes
in vitro (Biesinger et al., 1992), HVS research in the past
years focused on the transforming functions of subgroup
C strains, and their stpC gene products were studied in
detail. The oncoprotein StpC interacts with cellular Ras
(Jung and Desrosiers, 1995a), which is also able to sub-
stitute for StpC function in the viral context (Guo et al.,
1998). However, an ERK activation attributed to this in-
teraction in stably transfected fibroblasts (Jung and Des-
rosiers, 1995a) was not a common feature of the cell
lines derived from the HVS C-488-infected tamarin (Fig.
6A). As our experiments were performed under normal
culture conditions, further analyses will be needed to
evaluate the inducibility of ERKs and other MAPK family
members by different stimuli.
The second stpC gene product, Tip, interacts with the
T-cell-specific tyrosine kinase Lck in vitro and in trans-
formed human lymphocytes (Biesinger et al., 1995). This
interaction was also detectable in the tumor-derived
tamarin lymphocytes but had no effect on the kinase
activity (Fig. 5B). Although accompanied by a surprisingly
low Lck autophosphorylation in all Sag. oedipus cells
analyzed, the latter observation adds another aspect to
the data published so far. Jung and co-workers reported
on downregulation of Lck-mediated signal transduction
in Jurkat cells after retroviral transduction of Tip (Jung et
al., 1995c) while other groups describe an enzymatic
activation of Lck when Tip was added in vitro and in
different expression systems (Hartley et al., 1999; Lund et
al., 1997a; Wiese et al., 1996). These results may be
explained by a negative feedback induced in vivo by the
Tip-activated kinase. In this context, our observation may
represent the steady state of this regulatory process.
The constitutive upregulation of STAT3 phosphoryla-
tion we identified in all Sag. oedipus lymphocytes carry-
ing HVS C-488 (Fig. 6B) most likely results from the
expression of Tip C-488 in these cells. Tip C-484, derived
from HVS subgroup C strain 484, has previously been
reported to induce STAT3 activation only in the presence
of Lck (Lund et al., 1997b). The Tip fragment directly
involved in Lck interaction (Jung et al., 1995b) is sufficient
to mediate this effect (Lund et al., 1999). Thus, the STAT3
activation we now observe in HVS C-488 cells suggests
a functional interaction between Tip and Lck in trans-
formed tamarin lymphocytes which is not monitored by
an enhanced autophosphorylation of immunoprecipi-
tated Lck. In addition, association of Tip C-484 with
STAT3 requires a tyrosine residue located outside of the
Lck binding domain (Hartley and Cooper, 2000). A ty-
rosine to serine mutation of the corresponding residue in
Tip C-488 enhances Lck binding and downregulation of
Lck-mediated signal transduction (Guo et al., 1997; Jung
et al., 1995b). Therefore, downregulation of Lck-mediated
signaling and activation of STAT3 are separable func-
tions of the Lck–Tip complex. This dual functionality may
be reflected by our seemingly contradictory results on
the activities of Lck and STAT3 (Figs. 5B and 6B).
We observed a high Lyn activity in two of three HVS
C-488 cell lines (Fig. 5D). In vitro transformation of hu-
man T-cells by HVS C-488 or C-139 also induced Lyn
activity (Fickenscher et al., 1997; Wiese et al., 1996). Lyn
expression and promoter activation were detected in two
common marmoset cell lines showing enhanced cellular
activation after transformation with a recombinant HVS
C-488 mutated in the Lck-binding motif of Tip. In the
same study, Lyn was not upregulated in a cell line trans-
formed with wild-type virus (Duboise et al., 1998b). These
data indicate that Lyn activity may contribute to but is not
required for lymphocyte proliferation induced by HVS
C-488.
Among the HVS C-488 cells, Lyn activation coincided
with enhanced tyrosine phosphorylation of proteins mi-
grating at 60 and 90 kDa (Fig. 5A) and with ERK1/2
activity (Fig. 6A). As a similar correlation was not ob-
served in HVS A-11 cells with even higher Lyn activities
(Figs. 5D, 5A, and 6A), Lyn itself does not appear to
induce tyrosine phosphorylation or ERK1/2 activity but is
rather activated in parallel by the same stimulus.
The nature of this postulated signal is unknown, but
may involve viral gene products not absolutely required
for transformation and oncogenesis. One candidate may
be the viral superantigen homologue encoded by ORF14,
which induces T-cell proliferation (Duboise et al., 1998;
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Yao et al., 1996). This gene is transcribed in stimulated
HVS C-488-transformed human lymphocytes (Knappe et
al., 1997) and was found to be essential for lymphoma
development in common marmosets (Duboise et al.,
1998), but not in cottontop tamarins (Knappe et al.,
1998b). Likewise, the HVS ORF13 gene product vIL-17
supports T-cell proliferation (Yao et al., 1995), but is not
required for pathogenesis in cottontop tamarins (Knappe
et al., 1998a). The viral cyclin D homologue (ORF72)
stimulates entry into the S phase of the cell cycle and is
expressed in transformed common marmoset lympho-
cytes (Jung et al., 1994), but is not essential for in vitro
transformation of human and common marmoset lym-
phocytes nor for oncogenicity in cottontop tamarins (Ens-
ser et al., 2001). An antiapoptotic HVS protein, vFLIP,
expressed in HVS C-488 lymphocytes is also not re-
quired for lymphocyte transformation in vitro and lym-
phoma development in Sag. oedipus (Glykofrydes et al.,
2000). Finally, HVS URNAs assumed to be involved in
mRNA stabilization are transcribed in human HVS C-488
T-cells but are dispensable for their in vitro transforma-
tion (Ensser et al., 1999). In summary, in addition to StpC
and Tip, several viral factors may influence the activation
status of HVS C-488 lymphocytes and thus tyrosine
phosphorylation and Lyn and ERK activity in our HVS
C-488-infected Sag. oedipus lymphocytes.
Biochemical characteristics of HVS A-11 lymphocytes
The most intriguing finding of this study was the high
level of Lyn expression in both HVS A-11 cell lines, which
was accompanied by a high enzymatic activity of this
tyrosine kinase (Figs. 4 and 5D). The viral factors listed
as potential inducers of Lyn activity in HVS C-488 may
also be involved in Lyn induction in A-11 cells. However,
expression of Lyn is much higher in these cells, suggest-
ing that StpA provides additional or alternative regulatory
signals. Although the function of Src in T-cells is not
known, a stimulatory pathway may be initiated by the
direct interaction of this kinase with StpA. We were able
to detect the association of these two proteins and a
moderate increase in Src-related kinase activity in ly-
sates of HVS A-11 lymphocytes (Fig. 5C). Enzymatic ac-
tivation had not been observed in other expression sys-
tems (Lee et al., 1997) and may be specific to T-cells.
However, the functional relevance of StpA–Src interac-
tion and Lyn expression in HVS A-11 transformation
remains to be analyzed.
STAT3 was activated in one of the two HVS A-11 lines,
but the extent of activation-specific phosphorylation was
significantly lower than in C-488 lymphocytes (Fig. 6B).
This STAT3 activation in cell line A17 coincided with the
appearance of an unidentified 85-kDa phosphoprotein in
the Lck kinase assay (Fig. 5B). As discussed for HVS
C-488, viral factors promoting lymphocyte proliferation
without being essential for transformation may contrib-
ute to these phosphorylation events in this HVS A-11 line.
Lack of biochemical markers in HVS B-SMHI cells
Only a single lymphocyte line could be established
from the cottontop tamarin infected with HVS B-SMHI.
None of the pathways analyzed was specifically acti-
vated in these cells. In particular, the association of StpB
with Src (Choi et al., 2000; Ho¨r et al., 2001) was also
detected, but we obtained no evidence that StpB induced
Src kinase activity (Fig. 5C) or Lyn expression (Fig. 4).
The specific migration pattern of Src variants in the HVS
B-SMHI lane suggested a differential phosphorylation
and regulation of the kinase whose function is as yet
unclear.
The missing transforming functions of StpB in rodent
fibroblasts (Choi et al., 2000) and the restricted pathoge-
nicity of subgroup B strains gave rise to the hypothesis
that StpB does not contribute to transformation and that
other viral genes are sufficient to cause tumors in Sag.
oedipus. However, experiments with an HVS C-488 de-
letion mutant clearly demonstrated that StpC and Tip are
required for oncogenicity in cottontop tamarins (A. Ens-
ser, Erlangen, personal communication), indicating that
the remaining conserved viral genes are not sufficient to
induce lymphoma in this species. Therefore, we postu-
late that StpB plays a role in pathogenesis by HVS
B-SMHI although its biochemical targets are poorly de-
fined so far.
Perspectives
We identified Lyn expression and STAT3 activation as
characteristics of lymphocytes infected with HVS A-11
and C-488, respectively. Future experiments in other an-
imal species and with recombinant viruses mutated in
their stp genes will allow us to test for the role of
associated pathways in viral transformation and lympho-
cyte growth control.
MATERIALS AND METHODS
Propagation and reisolation of virus
OMK cells (ATCC CRL-1556) were maintained in
DMEM (Gibco BRL, Life Technologies, Karlsruhe, Ger-
many) supplemented with 10% fetal calf serum (FCS).
Subconfluent monolayers were infected with HVS strains
A-11 (Falk et al., 1972), B-SMHI (Daniel et al., 1974), and
C-488 (Biesinger et al., 1990; Desrosiers and Falk, 1982);
serial dilutions of these virus stocks; samples obtained
from monkey tissues; or cleared supernatants of lympho-
cyte cultures. Cultures were microscopically evaluated
for the development of specific cytopathic effects for up
to 4 weeks after infection. To produce high-titer virus
inoculum, supernatant of completely lysed cultures was
cleared by centrifugation at 2000 g for 10 min and stored
in aliquots at 80°C.
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Infection of monkeys and preservation of tissue
samples
Three Sag. oedipus monkeys were selected from the
colony at the German Primate Center for their inability to
produce offspring. The study was performed with per-
missions according to the national animal protection
regulations. The primates were infected with 1 ml (105
PFU) of the virus stocks containing HVS A-11, B-SMHI, or
C-488. When the animals died or were sacrificed, sam-
ples of multiple organs were taken and aliquots were
stored in tissue culture medium (at room temperature for
generation of cell lines), in paraformaldehyde (at room
temperature for paraffin embedding), in Tissue-Tec (deep
frozen for cryosections), or without additives (deep fro-
zen for DNA and RNA isolation). Samples for virus rei-
solation were collected from transport media and from
the initial cultures of tissue-derived cells (stored frozen
without additives). An excess of serum-free medium
used for transportation of fresh HVS C-488 samples led
to dilution of infectious virions and may have favored
their degradation.
Histology and immunohistochemistry
Tissue samples were fixed in formalin and embedded
in paraffin according to standard histological proce-
dures. For routine light microscopy, 3- to 5-m paraffin
sections were stained with hematoxylin and eosin. For
immunohistochemistry, paraffin sections were stained
with antibodies specific for CD20 and CD3 (Dako, Ham-
burg, Germany). These antibodies were shown to react
specifically with cottontop tamarin B- and T-cells, respec-
tively, in previous studies (Niedobitek et al., 1994). Immu-
nohistochemical staining was carried out as described
using a streptavidin–biotinylated alkaline phosphatase
complex (Dako) and Fast red as a chromogen
(Niedobitek et al., 1994).
In situ hybridization techniques
35S-labeled single-stranded antisense and sense RNA
probes were generated by in vitro transcription from
pcDNA3-based plasmids (Invitrogen, Groningen, The
Netherlands) harboring open reading frames of StpA,
StpB, or StpC as described (Niedobitek et al., 1991). In
situ hybridization was carried out as described in detail
elsewhere (Niedobitek et al., 1991). Briefly, paraffin sec-
tions were dewaxed and rehydrated through graded eth-
anols, treated with 0.2 N HCl for 20 min, digested with 0.5
mg/ml Pronase (Roche Diagnostics, Mannheim, Ger-
many) for 10 min, fixed in cold 4% paraformaldehyde for
20 min, and acetylated using a freshly prepared 1:400
solution of acetic anhydride in 0.1 M triethanolamine, pH
8.0, for 10 min. Sections were then dehydrated through
graded ethanols and air dried. Approximately 25 l of
hybridization mixture [50% deionized formamide, 10%
dextran sulfate, 2 standard saline citrate (SSC), 0.2
mg/ml yeast tRNA, 10 mM dithiothreitol (DTT)] containing
between 4  104 and 2  105 cpm of labeled probe was
added to each section. After hybridization overnight at
50°C sections were washed in 50% formamide, 1 SSC,
10 mM DTT at 52°C for 4 h. To remove nonspecifically
bound probe, sections were then subjected to RNase A
digestion (20 g/ml for 30 min at 37°C; Sigma, Deisen-
hofen, Germany). Sections were then rinsed in 2 SSC
and then 0.1 SSC, dehydrated through graded ethanols,
air dried, and dipped into Ilford G5 emulsion (Ilford,
Mobberley, Cheshire, UK). Coated sections were ex-
posed in darkness at 4°C, developed in Kodak D19, fixed
in 25% sodium thiosulfate, and counterstained with he-
matoxylin.
The plasmid pBS-H (kindly provided by H. Fickenscher,
Erlangen) contained two tandem copies of terminal re-
petitive HVS A-11 DNA (Bankier et al., 1985). Total plas-
mid DNA was labeled by nick translation using a com-
mercially available kit (Amersham Pharmacia Biotech,
Freiburg, Germany) in the presence of [35S]dCTP. For
DNA in situ hybridization, prehybridization treatment of
sections was as described above. Approximately 25 l of
hybridization mixture (50% deionized formamide, 10%
dextran sulfate, 10 mM DTT, 30 g/ml herring sperm
DNA, 20–40 ng/ml labeled probe) was added per slide.
Cellular and probe DNA was denatured at 90°C for 3 min
followed by hybridization overnight at 37°C. Sections
were then washed in a solution of 50% deionized form-
amide, 1 SSC, 10 mM DTT for 4 h, rinsed in 2 SSC
and 0.1 SSC, and processed further as described
above.
Lymphocyte culture
Fresh tissue samples from the infected monkeys were
mechanically disrupted. Blood samples were loaded on
Ficoll gradients (Ficoll separation solution used accord-
ing to the supplier’s instructions; Biochrom KG, Berlin,
Germany) to purify mononuclear cells. Initially, all pri-
mary cells were cultivated in complete RPMI medium
[RPMI 1640 (Gibco BRL) supplemented with 10% FCS,
glutamine, streptomycin, and penicillin]. After 1 week,
supernatants were removed for virus reisolation and
replaced by fresh complete RPMI medium. Cultivation
was continued with partial medium exchange every 4 to
7 days and, if necessary, with Ficoll gradient purification
to remove excess cell debris from the cultures. When
lymphocytes started to proliferate, culture volumes were
adjusted and aliquots of the cells were transferred to
IL-2-supplemented medium [45% Panserin (PAN Biotech,
Aidenbach, Germany) and 45% RPMI 1640 medium
(Gibco BRL) containing 10% FCS and 100 U recombinant
IL-2 (Aldesleukin/Proleukin; Chiron, Ratingen, Germany)
per milliliter or 20 U human IL-2 (Roche Diagnostics) per
milliliter). Negative samples were discarded after 20 to
80 days of cultivation. Positive cultures were kept for 2 to
3 months and cryoconserved at 80°C.
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All newly established cell lines used for further anal-
yses, primary Sag. oedipus T-cells line B133 (H. Ficken-
scher, Erlangen) and HVS C-488-transformed human
T-cells line CB15 (Biesinger et al., 1992) and line 3C
(Fickenscher et al., 1996), as well as the HVS C-488-
transformed rhesus lymphocytes SL11 (S. M. Lang, Er-
langen), were routinely maintained in IL-2-supplemented
medium. Tumor cell lines 70N2 and 1670 derived from
HVS A-11-infected cottontop and whitelip tamarins, re-
spectively (Fleckenstein and Desrosiers, 1982); the hu-
man T-leukemia cell line Jurkat, clone E6-1 (ATCC TIB-
152); and the human Burkitt lymphoma line BJAB (Clem-
ents et al., 1975) were cultivated in complete RPMI
medium.
Growth properties of the ex vivo cell lines were ana-
lyzed from month 1 to month 7 after thawing. Cultures
were monitored by light microscopy and kept at a density
of 5–15  105 cells/ml as determined by automated cell
counting (Micro Cell Counter F-300; Sysmex, Norder-
stedt, Germany). Doubling times were calculated from
data collected during the entire cultivation period. IL-2
dependence was tested in three independent experi-
ments. For the first two experiments, IL-2 was gradually
eliminated from the standard IL-2-supplemented me-
dium. For the third experiment, cells were sedimented
and resuspended in growth medium without IL-2. All
cultures, including IL-2-supplemented controls, were ob-
served for at least 4 weeks before evaluation.
For PCR, immunoblots, and kinase assays cells were
harvested, washed twice with phosphate-buffered sa-
line, pH 7.4 (PBS), and stored at 80°C.
FACS analysis
For each sample, 2  105 cells were sedimented,
washed with PBS, and resuspended in 30 l PBS con-
taining 5% FCS and 0.1% sodium azide (PBS–FCS). After
the addition of 3 l phycoerythrin-conjugated anti-CD2
(RPA-2.10), anti-CD3 (SP34), anti-CD4 (Leu3a), or anti-
CD8 (RPA-T8; BD Biosciences, Heidelberg, Germany) an-
tibodies, cells were incubated on ice for 30 min. After two
washing steps with PBS–FCS cells were resuspended in
200 l PBS. CD20 was detected in saponin-permeabi-
lized cells by antibodies reactive with its conserved cy-
toplasmic part (dilution 1:50; L26; Dako) followed by
fluorescein isothiocyanate-conjugated anti-mouse im-
munoglobulin antibodies (dilution 1:130; Dako) according
to standard procedures. Data were collected on a FAC-
SCalibur and analyzed with the program WinMDI version
2.8 (facs.scripps.edu).
PCR techniques
Total cellular DNA was prepared from 5  105 cells by
lysis in 100 l K buffer (50 mM KCl, 15 mM Tris–HCl, pH
8.0, 2.5 mM MgCl2, 0.5% Tween 20, 100 g/ml proteinase
K) for 45 min at 56°C followed by an inactivation step of
10 min at 95°C. Lysates were cleared for 1 min at 15,000
rpm and stored at 20°C. Total cellular RNA was pre-
pared using the High Pure RNA Isolation Kit (Roche
Diagnostics). Reverse transcription was carried out ac-
cording to the SMART cDNA protocol (Clontech, Heidel-
berg, Germany). PCRs were performed with 2 l DNA or
cDNA in a total volume of 30 l buffer containing 200 M
each dNTPs, 10 M each primer, and 0.3 l recombinant
Taq polymerase (Perkin–Elmer, Rodgau-Ju¨gesheim, Ger-
many). PCR conditions were as follows: a 1-min dena-
turation step at 96°C followed by 35 cycles of 15 s at
96°C, 30 s at 55°C (58°C for stpC), and 30 s at 72°C (40
s for stpC) and a final 1-min extension at 72°C (2 min for
stpC). The following gene-specific primer pairs were
used: stpA (5-TGG CAA GAG GTC TAG GTG AAG-3 and
5-ACA TTT TTT TAA ACA TAA TTA CTA GC-3), stpB
(5-GCG TGG GGT TTA GGC CCT C-3 and 5-CTA CAA
TTT CCA GTA TCG TAG C-3), stpC (5-GTA GTA AAC TAA
GAG CAA AGC AAG C-3 and 5-GTA CAA GCT GTT CAA
GTT TGT TAG C-3), ORF3 (5-CAC AAC ACT GGT ATG
TAC CAA TG-3 and 5-CTG TGG AGG TAA TGC AGA
TAC-3), and ORF75 (5-TGG CTG CTA ACA GGC ATG
G-3 and 5-AGC ACG TTG CCC GAG ATT G-3). PCR
products were separated on 1.5% agarose gels.
Antibodies
Antibodies reactive with Fyn (Fyn3), Hck (N-30), JNK
(C-17), Lyn (H-6), p38 (C-20), phospho-ERK (E-4), phos-
pho-JNK (G-7), phospho-p38 (D-8), phospho-STAT3 (B-7),
SLP76 (H-300), Src (SRC2), Syk (4D10), TRAF1 (H186),
TRAF2 (C-20), TRAF3 (G-6), and Vav (C-14) were pur-
chased from Santa Cruz Biotechnology (Heidelberg, Ger-
many). Antibodies specific for ERK (panERK) and STAT3
(S21320) were from Transduction Laboratories (BD Bio-
sciences). Antibodies binding to LAT and to phosphoty-
rosine (4G10) were obtained from Upstate Biotechnology
(Biomol, Hamburg, Germany) and anti-panRas (Ab-4)
from Oncogene Research Products (Calbiochem–Nova-
biochem, Bad Soden, Germany). A rabbit serum reactive
with Zap70 and monoclonal antibodies against Lck (IF6)
were kindly provided by N. Isakov (Beer Sheva, Israel)
and by J. Bolen (Princeton, NJ), respectively. A polyclonal
serum generated by immunization of a guinea pig with a
GST fusion protein of the Lck amino-terminal domain
was used to immunoprecipitate Lck. Horseradish-perox-
idase-conjugated secondary antibodies against mouse
(P0260) and rabbit (P0217) were obtained from DAKO.
Immunoblot
Cell lysis was performed as previously described
(Biesinger et al., 1995). Protein concentrations were de-
termined by the BCA assay (Pierce, Rockford, IL), 12 g
total cellular proteins per lane were separated by SDS–
PAGE and transferred to polyvinylidene difluoride mem-
branes (Immobilon-P; Millipore, Bedford). Membranes
were incubated for 1 h at room temperature or at 4°C
overnight with primary antibodies diluted in PBS contain-
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ing 0.1% Tween 20 and 3% dry milk powder. For anti-
phosphotyrosine immunoblots the buffer was composed
of 150 mM NaCl, 50 mM Tris–HCl, pH 7.5, 5 mM EDTA,
0.25% gelatin, 0.05% Triton X-100. Secondary antibodies
were applied at a dilution of 1:2000 in the same buffers
for 30–60 min at room temperature. Detection was per-
formed as described by the manufacturer of the en-
hanced chemiluminescence system (Amersham Phar-
macia Biotech, Freiburg, Germany).
In vitro protein kinase assay
Cell lysates were adjusted to 1 ml with TNE buffer (150
mM NaCl, 50 mM Tris–HCl, pH 8.0, 2 mM EDTA, 1%
NP-40), incubated with specific antibodies at 4°C for at
least 1 h and for an additional 30 min after the addition
of protein A–Sepharose (Sepharose CL-4B; Amersham
Pharmacia Biotech). Immunoprecipitates were washed
twice in TNE buffer, once in 10 mM Tris–HCl, pH 7.4, and
once in kinase buffer (20 mM HEPES, 5 mMMgCl2, 5 mM
MnCl2). In vitro phosphotransferase reactions were per-
formed as described previously (Lang et al., 1997). After
separation by SDS–PAGE, 32P-labeled proteins were vi-
sualized by autoradiography.
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